Jiyuan Tu

647 total citations
23 papers, 508 citations indexed

About

Jiyuan Tu is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Jiyuan Tu has authored 23 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Complementary and alternative medicine and 4 papers in Pharmacology. Recurrent topics in Jiyuan Tu's work include Traditional Chinese Medicine Analysis (8 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Ginseng Biological Effects and Applications (3 papers). Jiyuan Tu is often cited by papers focused on Traditional Chinese Medicine Analysis (8 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Ginseng Biological Effects and Applications (3 papers). Jiyuan Tu collaborates with scholars based in China, Australia and United States. Jiyuan Tu's co-authors include Yanju Liu, Guosheng Cao, Zhongshi Zhou, Linghang Qu, Guojun Zhang, Shuiqing Li, Kun Shi, Z. J. Sun, Dan Jin and Kang Xu and has published in prestigious journals such as Analytical Chemistry, The Science of The Total Environment and Journal of Agricultural and Food Chemistry.

In The Last Decade

Jiyuan Tu

22 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiyuan Tu China 13 323 92 87 85 38 23 508
He Tu China 8 193 0.6× 50 0.5× 41 0.5× 53 0.6× 12 0.3× 9 392
Dongchun Liu China 14 177 0.5× 26 0.3× 88 1.0× 60 0.7× 13 0.3× 34 482
Yinzi Yue China 14 164 0.5× 45 0.5× 13 0.1× 41 0.5× 61 1.6× 32 396
Yue Wan China 11 314 1.0× 26 0.3× 16 0.2× 72 0.8× 24 0.6× 22 506
Yaonan Wang China 12 192 0.6× 26 0.3× 44 0.5× 41 0.5× 50 1.3× 61 485
Qiongqiong Li China 12 225 0.7× 21 0.2× 39 0.4× 25 0.3× 12 0.3× 32 487
Pengbo Wen China 12 251 0.8× 17 0.2× 70 0.8× 7 0.1× 39 1.0× 24 517
Hengfeng Liao China 6 125 0.4× 53 0.6× 31 0.4× 48 0.6× 13 0.3× 8 380
Xiaxia Wu China 10 283 0.9× 73 0.8× 72 0.8× 47 0.6× 48 1.3× 16 629

Countries citing papers authored by Jiyuan Tu

Since Specialization
Citations

This map shows the geographic impact of Jiyuan Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiyuan Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiyuan Tu more than expected).

Fields of papers citing papers by Jiyuan Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiyuan Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiyuan Tu. The network helps show where Jiyuan Tu may publish in the future.

Co-authorship network of co-authors of Jiyuan Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiyuan Tu. A scholar is included among the top collaborators of Jiyuan Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiyuan Tu. Jiyuan Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Qingsong, Y. H. Lin, Jiyuan Tu, et al.. (2025). Shenfu injection ameliorates hepatic ischemia-reperfusion injury through induction of ferroptosis via JAK2/STAT3 pathway. Journal of Ethnopharmacology. 348. 119889–119889. 1 indexed citations
2.
Shi, Kun, Bin Wu, Jiyuan Tu, et al.. (2024). Mechanism of Shenfu Injection in Treating Ischemic Stroke Elucidated using Network Pharmacology and Experimental Validation. Current Computer - Aided Drug Design. 21(6). 793–806.
3.
Wang, Dongpeng, et al.. (2024). Artificial aging conditions for Artemisia argyi leaves based on quality-inflammation-quality marker transformation. Phytomedicine. 129. 155574–155574. 2 indexed citations
4.
Tu, Jiyuan, et al.. (2024). DSN signal amplification strategy based nanochannels biosensor for the detection of miRNAs. Bioelectrochemistry. 160. 108771–108771. 6 indexed citations
5.
Zhang, Ya, Tian Lin, Jiyuan Tu, et al.. (2024). Investigation of inter-subject variation in ultrafine particle deposition across human nasal airways: A study involving children, adults, and the elderly. The Science of The Total Environment. 955. 177028–177028. 5 indexed citations
6.
Shi, Kun, Yan Wang, Jiyuan Tu, et al.. (2023). Therapeutic effects and mechanism of Atractylodis rhizoma in acute lung injury: Investigation based on an Integrated approach. Frontiers in Pharmacology. 14. 1181951–1181951. 8 indexed citations
7.
Zhan, Xin, et al.. (2023). Integrated analysis of metabolomic and transcriptomic profiling reveals the effect of Atractylodes oil on Spleen Yang Deficiency Syndrome in rats. Journal of Ethnopharmacology. 319(Pt 2). 117205–117205. 9 indexed citations
8.
Wang, Yan, Kun Shi, Jiyuan Tu, et al.. (2023). Atractylenolide III Ameliorates Bile Duct Ligation-Induced Liver Fibrosis by Inhibiting the PI3K/AKT Pathway and Regulating Glutamine Metabolism. Molecules. 28(14). 5504–5504. 14 indexed citations
10.
11.
Li, Kun, Jiyuan Tu, Yulin Zhang, et al.. (2022). Ultrasensitive detection of exosomal miRNA with PMO-graphene quantum dots-functionalized field-effect transistor biosensor. iScience. 25(7). 104522–104522. 37 indexed citations
12.
Tu, Jiyuan, et al.. (2022). Ganfule capsule alleviates bile duct ligation-induced liver fibrosis in mice by inhibiting glutamine metabolism. Frontiers in Pharmacology. 13. 930785–930785. 9 indexed citations
13.
Shi, Kun, Yan Dong, Dongpeng Wang, et al.. (2022). Protective Effects of Atractylodis lancea Rhizoma on Lipopolysaccharide-Induced Acute Lung Injury via TLR4/NF-κB and Keap1/Nrf2 Signaling Pathways In Vitro and In Vivo. International Journal of Molecular Sciences. 23(24). 16134–16134. 20 indexed citations
14.
Xie, Ying, Xin Zhan, Jiyuan Tu, et al.. (2021). Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF/c-kit and MLCK/MLC2 pathways. Journal of Ethnopharmacology. 272. 113925–113925. 57 indexed citations
15.
Lei, Lin, Linghang Qu, Lin Xiong, et al.. (2021). Identification of different bran-fried Atractylodis Rhizoma and prediction of atractylodin content based on multivariate data mining combined with intelligent color recognition and near-infrared spectroscopy. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 262. 120119–120119. 19 indexed citations
16.
Tu, Jiyuan, et al.. (2021). Peptide Nucleic Acid-Functionalized Nanochannel Biosensor for the Highly Sensitive Detection of Tumor Exosomal MicroRNA. Analytical Chemistry. 93(31). 10966–10973. 53 indexed citations
17.
Tu, Jiyuan, Zhongshi Zhou, Yanju Liu, et al.. (2021). Nanochannel-based sensor for the detection of lead ions in traditional Chinese medicine. RSC Advances. 11(6). 3751–3758. 18 indexed citations
18.
Qu, Linghang, Guosheng Cao, Kang Xu, et al.. (2020). Effects of Atractylodes Oil on Inflammatory Response and Serum Metabolites in Adjuvant Arthritis Rats. Biomedicine & Pharmacotherapy. 127. 110130–110130. 44 indexed citations
19.
Tu, Jiyuan, Ying Xie, Kang Xu, et al.. (2020). Treatment of Spleen-Deficiency Syndrome With Atractyloside A From Bran-Processed Atractylodes lancea by Protection of the Intestinal Mucosal Barrier. Frontiers in Pharmacology. 11. 583160–583160. 24 indexed citations
20.
Shi, Kun, Linghang Qu, Ying Xie, et al.. (2019). Deep-Fried Atractylodis Rhizoma Protects against Spleen Deficiency-Induced Diarrhea through Regulating Intestinal Inflammatory Response and Gut Microbiota. International Journal of Molecular Sciences. 21(1). 124–124. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026